Chemotherapy Market Insights, 2006-2016: A Critical Analysis of Cancer Research, Treatments, Pipelines, and Commercial Opportunities - Market Research Reports

Welcome - Home - Register - Login - Help/FAQ - 0 items

Search
Enter keywords, a title or
a report id number below.

Advanced


	Select a currency for use throughout the site

Viewing report

Order by Fax
Printer Friendly
PDF Brochure
Send to Friend
Enquire before Buying

| More

Electronic (PDF)
1 - 5 Users
Enterprisewide

Chemotherapy Market Insights, 2006-2016: A Critical Analysis of Cancer Research, Treatments, Pipelines, and Commercial Opportunities
Spectra Intelligence , April 2006, Pages: 369



		Description



		Table of Contents



		Summary


	Companies Mentioned



		Enquire before Buying



		Send to a Friend

- ABBOTT LABORATORIES
- ACCESS PHARMA
- ADVENTRIX PHARMA
- AEGERA THERAPEUTICS
- AKZO NOBEL
- ALCON LABORATORIES
- ALLERGAN
- ALTANA
- ALTUS PHARM
- AMGEN
- ANTIGENICS
- ANTISENSE PHARMA
- ANTISOMA
- APHTON
- ARIAD PHARMA
- ARQULE
- ASTRAZENECA
- AVALON PHARMA
- AVAX TECHNOLOGIES
- AVIDEX
- BAXTER INTERNATIONAL
- BAYER
- BIOGEN IDEC
- BIONUMERIK PHARM
- BIOTICA
- BIOVEST INTERNATIONAL
- BOEHRINGER-INGELHEIM
- BRISTOL-MYERS SQUIBB
- CALLISTO PHARMA
- CAPRION PHARM
- CELGENE
- CELL GENESYS
- CELL THERAPEUTICS
- CHEMGENEX PHARM
- CHUGAI
- CHIRON
- COLEY PHARMA
- CONFORMA
- DYNAVAX TECHNOLOGY CORP
- ECOPIA PHARMACEUTICAL COMPANY
- EISAI
- ELI LILLY
- ENZON PHARMA
- ERCOLE
- EXIMIAS PHARMA
- FOREST LABS
- FUJISAWA
- GENAERA
- GENENTECH
- GENITOPE CORP
- GENZYME
- GERON PHARMACEUTICALS
- GLAXOSMITHKLINE
- GPC BIOTECH
- HELIX BIOPHARMA
- HYBRIDON
- IDERA PHARMA
- IDUN PHARMA
- IMCLONE SYSTEMS
- IMMUNOGEN
- IMMUSOL
- INEX PHARMA
- INFINITY PHARMA
- INOVIO
- ISIS PHARMA
- IVAX
- JOHNSON & JOHNSON
- KING PHARMACEUTICALS
- KOSAN BIOSCIENCES
- LIGAND PHARMA
- LIGHT SCIENCES
- LUNDBECK
- MAXIM PHARMA
- MEDAREX
- MEDIGENE
- MEDIMMUNE
- MERCK & CO.
- MILAGEN
- MILLENNIUM PHARMACEUTICALS
- MITSUBISHI PHARMA
- MORPHOSYS
- MYLAN LABS
- NEORX
- NOVARTIS
- NOVO NORDISK
- ONCOGENIX
- ONCOLYTICS BIOTECH
- ONO
- ONYX PHARMA
- ORGANON
- ORTHO BIOTECH
- OSI PHARMA
- OTSUKA
- PANACEA PHARMA
- PENEGRINE PHARMA
- PFIZER
- PROLEXYS PHARMA
- PROTHERICS
- PROVECTUS PHARMA
- PURDUE PHARMA
- QUARK BIOTECH
- RECEPTOR BIOLOGIX
- REGENERON PHARMACEUTICALS
- ROCHE
- SANKYO
- SANOFI-AVENTIS
- SCHERING AG
- SCHERING-PLOUGH
- SEMAFORE PHARMA
- SERONO
- SGX PHARMA
- SHIONOGI SEIYAKU
- SHIRE
- SOLVAY
- SPECTRUM PHARMA
- STARPHARMASUNESIS PHARMA
- SYNTA PHARMA
- SYRRX
- TAKEDA
- TANABE SEIYAKU
- TAP PHARMACEUTICAL
- TAPESTRY PHARMA
- TEVA
- THERION BIOLOGICS
- TRANSGENE
- U3 PHARMA
- UCB
- VAXON BIOTECH
- VERTEX PHARMACEUTICALS
- VION PHARMA
- VIVENTIA BIOTECH
- WATSON
- WYETH
- XOMA
- YAMANOUCHI
- YM BIOSCIENCES
- ZYMO GENETICS

Product samples

A sample for this product is available. Please Login/Register to download this sample.

Customers who bought this item also bought

Cancer Chemotherapy: Basic Science to the Clinic

Cancer Therapeutics Markets

Triple Analysis: The Drug Target Atlas of Apoptopic Drugs in Oncology and Special Focus on Lung Cancer and Melanoma

Cancer Drug Discoveries: What the Future Holds: Prostate Cancer Chapter

The Cancer Clock

Drug Delivery in Cancer - Technologies, Markets and Companies

Cancer Therapeutics - Market Insight and R&D Pipeline Analysis

Prostate Cancer Therapeutics - Global Strategic Business Report

European Bladder Cancer Therapeutics Markets

Cancer Therapies - Global Strategic Business Report

Triple Analysis: The Drug Target Atlas of Apoptopic Drugs in Oncology and Special Focus on Breast and Prostate Cancer

Cancer Drug Discoveries: What the Future Holds: Non-Small Cell Lung Cancer Chapter

Top of page